Literature DB >> 26804231

Design and synthesis of substituted pyrido[3,2-d]-1,2,3-triazines as potential Pim-1 inhibitors.

Yin-Bo Fan1, Kun Li1, Min Huang1, Yu Cao1, Ying Li2, Shu-Yu Jin1, Wen-Bing Liu1, Jia-Chen Wen1, Dan Liu3, Lin-Xiang Zhao4.   

Abstract

A novel series of substituted pyrido[3,2-d]-1,2,3-triazines were designed and synthesized as Pim-1 inhibitors through scaffold hopping. Most of the derivatives showed potent in vitro Pim-1 inhibitory activities and anti-proliferative effects toward prostate cancer cells. Among them, 6b, 6h and 6m showed the best Pim-1 inhibitory activity with IC50 values of 0.69, 0.60 and 0.80 μM, respectively. Furthermore, compounds 6b, 6i, 6j and 6m showed strong inhibitory activity to human prostate cancer LNcap and PC-3 cell lines with IC50 values at low micromolar level. Structure-activity relationship analysis revealed that appropriate substitutions at C-6 positions contributed to the kinase inhibition and antiproliferative effects. Moreover, western blot assay suggested that 6j could decrease the levels of p-BAD and p-4E-BP1 in a dose-dependent manner in PC-3 cells. Docking studies showed that 3-N of the scaffold formed a hydrogen bond with Lys67, aromatic 4-aniline formed a key π-π stack with Phe49. Taken together, this study might provide the first sight for developing the pyrido[3,2-d]-1,2,3-triazine scaffold as novel Pim-1 inhibitors.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Anti-proliferative activity; Pim-1 kinase inhibitors; Prostate cancer cells; Pyrido[3,2-d]-1,2,3-triazines

Mesh:

Substances:

Year:  2016        PMID: 26804231     DOI: 10.1016/j.bmcl.2016.01.032

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  PIM1 inhibitor synergizes the anti-tumor effect of osimertinib via STAT3 dephosphorylation in EGFR-mutant non-small cell lung cancer.

Authors:  Ziyi Sun; Liang Zeng; Miaomiao Zhang; Yongchang Zhang; Nong Yang
Journal:  Ann Transl Med       Date:  2020-03

2.  PIM-1 Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients.

Authors:  Athina Markou; Eleni Tzanikou; Areti Strati; Martha Zavridou; Sophia Mastoraki; Evangelos Bournakis; Evi Lianidou
Journal:  Cancers (Basel)       Date:  2020-05-08       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.